HSPA5 and rheumatoid arthritis: The overall diagnostic odds ratio (DOR) was notably high at 23.73, while the pooled positive likelihood ratio (LR+) was 8, indicating that individuals diagnosed with RA are eight times more likely to test positive for biomarkers associated with GRP78/BiP compared to those without the condition.